[Click eStock] "Structural Growth of Health Functional Food Companies... Stock Price Revaluation Expected"

[Asia Economy Reporter Hyungsoo Park] An analysis has emerged that health functional food companies listed on the domestic stock market are undervalued compared to their earnings growth rate.

Daishin Securities analyzed on the 4th that the combined sales and operating profit of 8 major health functional food companies in the fourth quarter of last year increased by 66.8% and 83.9%, respectively, compared to the same period last year.

Researcher Han Kyung-rae of Daishin Securities explained, "Structural growth due to the aging population, along with popular brands such as Lactofit, Evercollagen, and Hemohim, led the increase in sales."

He identified Nutri, Kolmar BNH, and Novarex as preferred stocks. Researcher Han said, "Nutri has established itself as a representative collagen brand in the expanding inner beauty market," adding, "If it obtains Chinese health food approval, a definite stock price revaluation is expected."

He continued, "Kolmar BNH's sales related to Atomy are expected to increase steadily," and "New clients are also expected to increase."

Researcher Han predicted, "Novarex holds the largest number of individually recognized ingredients in Korea," and "It will directly benefit from the growing health functional food market."

Furthermore, he analyzed, "Structural growth is expected due to demographic and socio-structural changes," and "The price-to-earnings ratio (PER) based on this year's expected earnings for the health functional food sector is only around 9 times."

This content was produced with the assistance of AI translation services.